Biomarkers and Diagnostic Innovations focuses on the development of advanced diagnostic tools and biomarker-based approaches for early detection, monitoring, and personalized treatment of endocrine and metabolic disorders. This scientific session explores molecular diagnostics, genetic testing, laboratory innovations, predictive biomarkers, and precision diagnostic technologies.
The session brings together researchers, clinicians, laboratory specialists, and healthcare professionals to discuss cutting-edge diagnostic advancements that support accurate disease management and improved patient outcomes.